These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19372545)

  • 41. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
    Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.
    Bodur C; Karakas B; Timucin AC; Tezil T; Basaga H
    Mol Carcinog; 2016 Nov; 55(11):1584-1597. PubMed ID: 26373689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.
    Xiang X; Saha AK; Wen R; Ruderman NB; Luo Z
    Biochem Biophys Res Commun; 2004 Aug; 321(1):161-7. PubMed ID: 15358229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.
    Inoue T; Yoshida T; Shimizu Y; Kobayashi T; Yamasaki T; Toda Y; Segawa T; Kamoto T; Nakamura E; Ogawa O
    Mol Endocrinol; 2006 Dec; 20(12):3053-69. PubMed ID: 16931574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
    Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
    Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
    Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
    J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
    Zadra G; Photopoulos C; Tyekucheva S; Heidari P; Weng QP; Fedele G; Liu H; Scaglia N; Priolo C; Sicinska E; Mahmood U; Signoretti S; Birnberg N; Loda M
    EMBO Mol Med; 2014 Apr; 6(4):519-38. PubMed ID: 24497570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.
    Singh RK; Lokeshwar BL
    Mol Cancer; 2009 Jul; 8():57. PubMed ID: 19646263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
    Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
    Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells.
    Lee YK; Park SY; Kim YM; Park OJ
    Ann N Y Acad Sci; 2009 Aug; 1171():489-94. PubMed ID: 19723094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
    Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
    Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin.
    Lee YK; Park SY; Kim YM; Lee WS; Park OJ
    Exp Mol Med; 2009 Mar; 41(3):201-7. PubMed ID: 19293639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
    Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
    Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin.
    Liu C; Liang B; Wang Q; Wu J; Zou MH
    J Biol Chem; 2010 May; 285(20):15346-15355. PubMed ID: 20233722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.
    He M; Tan B; Vasan K; Yuan H; Cheng F; Ramos da Silva S; Lu C; Gao SJ
    J Pathol; 2017 Jul; 242(3):309-321. PubMed ID: 28393364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.